Peter H Addy – Psychedelics, Hallucinogens and Entheogens – What Clinicians Need to Know

Peter H Addy – Psychedelics, Hallucinogens and Entheogens – What Clinicians Need to Know

Check it out: Peter H Addy – Psychedelics, Hallucinogens and Entheogens – What Clinicians Need to Know

Would you be able to spot your clients’ recreational use of psychedelics? What does psychedelic use mean for them (and you) in therapy? Would any of your clients benefit from a psychedelic experience? How will you know? How will you navigate the ethical dilemmas that may arise in session?

Many of us were taught nothing about psychedelics, or were given out-of-date information based on early Prohibition era stories and policies. Psychedelic-assisted psychotherapy is effective in the treatment of a variety of mental health conditions, and the FDA has both approved phase III clinical trials and expanded access. But there are gaps between clinician awareness of psychedelic use, how psychedelics are used in carefully designed clinical trials, and how your clients use them in the real world.

Complete this online training to bridge those gaps and confidently address your clients’ questions and experiences. You’ll acquire the skills you need to navigate common ethical dilemmas that may arise from talking with your clients about possibly illegal activity.

By completing this course, you’ll discover why clients use psychedelic substances and how this may impact their treatment.

In this workshop, you will learn:

• Types of psychedelic substances & their effects
• How & why psychedelics are used
• How to talk to your clients about psychedelic substances
• Updates on research of the effectiveness of psychedelics

Purchase today, and get need-to-know information on psychedelic substances, a better understanding of the research and navigate these changing times!